Minimum effective volume of 0.5% ropivacaine for ultrasound-guided costoclavicular brachial plexus block: A dose finding study.
Eur J Anaesthesiol. 2020 Sep; 37(9):780-786.EJ

Abstract

BACKGROUND

Costoclavicular brachial plexus block (CC-BPB) is a relatively new regional anaesthetic technique and there are no data on the minimum effective volume 90 (MEV90) of 0.5% ropivacaine required for an ultrasound-guided CC-BPB.

OBJECTIVE

To determine the MEV90 of 0.5% ropivacaine required to produce surgical anaesthesia with an ultrasound-guided CC-BPB.

DESIGN

Prospective up-down sequential allocation study design.

SETTING

University teaching hospital in Hong Kong from March 2016 to December 2017.

PATIENTS

Forty-eight, ASA physical status I to III patients, aged 70 years or less and scheduled for elective forearm or hand surgery under an ultrasound-guided CC-BPB, were recruited.

INTERVENTION

Ultrasound-guided CC-BPB was performed with the assigned volume of 0.5% ropivacaine. The Dixon 'up-and-down' sequential allocation method using the biased coin design was used to determine the MEV90 of 0.5% ropivacaine. The assigned volume of ropivacaine was based on the outcome of the previous patient. After a block failure the next patient received a volume increase of 2 ml. If the block was a success, the next patient was allocated, with a probability of b = 0.11, to receive 2 ml less, or, with a probability of 1 - b = 0.89, the same volume.

MAIN OUTCOME MEASURES

A successful block was defined as a minimum score of 14 of 16 points, using a composite sensory and motor block score at 45 min after the injection. The study was stopped when 45 successful blocks were achieved. MEV90 with 95% confidence interval was calculated using the centred isotonic regression for point and interval dose response studies.

RESULTS

The MEV90 of 0.5% ropivacaine for ultrasound-guided CC-BPB was 20.9 (95% confidence interval, 20.7 to 21.8) ml. The mean ± SD time to readiness for surgery was 31.4 ± 12.60 min.

CONCLUSION

The MEV90 of 0.5% ropivacaine required to produce surgical anaesthesia with an ultrasound-guided CC-BPB is 20.9 ml.

CLINICAL TRIAL REGISTRATION

The trial was registered with the Chinese Clinical Trials Registry (www.chictr.org.cn, ChiCTR-IOR-15007515, principal investigator: Manoj Kumar Karmakar, date of registration: 4 December 2015).

CLINICAL TRIAL NUMBER AND REGISTRY URL

ChiCTR-IOR-15007515, Chinese Clinical Trials Registry (www.chictr.org.cn).

Links

Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

Wong MH
From the Department of Anaesthesia & Intensive Care, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong, China (MHW, MKK, LYHM, BS, WS).
Karmakar MK
No affiliation info available
Mok LYH
No affiliation info available
Songthamwat B
No affiliation info available
Samy W
No affiliation info available

MeSH

AgedAmidesAnesthetics, LocalBrachial PlexusBrachial Plexus BlockHumansProspective StudiesRopivacaineUltrasonography, Interventional

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32740321